Randomized phase II study of preoperative concurrent chemoradiotherapy with or without induction chemotherapy with S-1 and oxaliplatin in patients with resectable esophageal cancer.

被引：0

作者：

Yoon, Dok Hyun

Jang, Geundoo

Kim, Jong Hoon

Kim, Yong Hee

Son, Seyoung

Kim, Jiyoun

Park, Seung-Il

Kim, Hyeong Ryul

Jung, Hwoon-Yong

Lee, Gin-Hyug

Choi, Kee Don

Song, Ho June

Song, Ho Young

Shin, Ji Hoon

Cho, Kyung-Ja

Kim, Sung-Bae

机构：

[1] Univ Ulsan, Dept Oncol, Asan Med Ctr, Coll Med, Seoul, South Korea

[2] Hallym Univ, Med Ctr, Coll Med, Seoul, South Korea

[3] Univ Ulsan, Dept Radiat Oncol, Asan Med Ctr, Coll Med, Seoul, South Korea

[4] Univ Ulsan, Dept Thorac Surg, Asan Med Ctr, Coll Med, Seoul, South Korea

[5] Univ Ulsan, Dept Gastroenterol, Asan Med Ctr, Coll Med, Seoul, South Korea

[6] Univ Ulsan, Dept Gastroentergol, Asan Med Ctr, Coll Med, Seoul, South Korea

[7] Univ Ulsan, Dept Radiol, Asan Med Ctr, Coll Med, Seoul, South Korea

[8] Univ Ulsan, Dept Pathol, Asan Med Ctr, Coll Med, Seoul, South Korea

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 15期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

4093

引用

页数：1

共 50 条

[41] A phase II study of induction chemotherapy with gemcitabine plus S-1 followed by chemoradiotherapy for locally advanced pancreatic cancer
Nakachi, Kohei
Furuse, Junji
Kinoshita, Taira
Kawashima, Mitsuhiko
Ishii, Hiroshi
Ikeda, Masafumi
Mitsunaga, Shuichi
Shimizu, Satoshi
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2010, 66 (03) : 527 - 534
[42] Efficacy and safety of preoperative chemoradiotherapy with S-1 for advanced rectal cancer: a phase II study
Ushigome, Mitsunori
Funahashi, Kimihiko
Kaneko, Tomoaki
Kagami, Satoru
Yoshida, Kimihiko
Miura, Yasuyuki
Koda, Takamaru
Nagashima, Yasuo
Kurihara, Akiharu
Terahara, Atsuro
REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY, 2023, 28 (01) : 36 - 46
[43] A phase II study of irinatecan and docetaxel with concurrent radiotherapy as preoperative treatment in resectable esophageal cancer
Posey, JA
Thornton, J
Russo, S
Cerfolio, R
Heslin, M
Eloubeidi, M
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 374S - 374S
[44] Phase II study of irinotecan/S-1 combination chemotherapy for patients with oxaliplatin-refractory colorectal cancer
Sung Yong Oh
Young-Tae Ju
Sang-Kyung Choi
Chang Yoon Ha
Won Sup Lee
Hoon Gu Kim
Gyeong-Won Lee
Hyuk-Chan Kwon
Jung Hun Kang
Investigational New Drugs, 2011, 29 : 1050 - 1056
[45] Phase II study of irinotecan/S-1 combination chemotherapy for patients with oxaliplatin-refractory colorectal cancer
Oh, Sung Yong
Ju, Young-Tae
Choi, Sang-Kyung
Ha, Chang Yoon
Lee, Won Sup
Kim, Hoon Gu
Lee, Gyeong-Won
Kwon, Hyuk-Chan
Kang, Jung Hun
INVESTIGATIONAL NEW DRUGS, 2011, 29 (05) : 1050 - 1056
[46] A PHASE II STUDY OF COMBINATION CHEMOTHERAPY WITH S-1 AND OXALIPLATIN IN PATIENTS WITH RECURRENT UNRESECTABLE OR METASTATIC BILIARY CANCER
Jang, G.
Kim, T. W.
Lee, S. S.
Sym, S. J.
Lee, J.
Ryu, M.
Chang, H. M.
Kang, Y.
Lee, J.
ANNALS OF ONCOLOGY, 2008, 19 : 177 - 177
[47] A phase II study of S-1 in patients with metastatic pancreatic cancer.
Furuse, J
Okusaka, T
Funakoshi, A
Boku, N
Yamao, K
Ohkawa, S
Saito, H
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 333S - 333S
[48] Definitive concurrent chemoradiotherapy using S-1 in the treatment of elderly patients with esophageal cancer
Jia, Y.
ANNALS OF ONCOLOGY, 2016, 27
[49] A prospective phase II trial of a S-1/cisplatin-based chemoradiotherapy for locoregionally advanced esophageal cancer.
Cho, Byoung Chul
Chang, Hyun
Lee, Yong Chan
Kim, Dae Joon
Yun, Mi Jin
Shin, Sung Kwan
Kim, Hyun Ki
Kim, Han Sang
Lim, Sun Min
Kim, Joo-Hang
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
[50] Randomized controlled phase II study of alternate-day S-1 as adjuvant chemotherapy for gastric cancer.
Nakamura, Seiichi
Tatebe, Shigeru
Shimizu, Tetsu
Yamane, Nariyuki
Nishidoi, Hideaki
Kurisu, Yasuro
Kanayama, Hirotomo
Ogawa, Haruaki
Tsujitani, Shunichi
Ikeguchi, Masahide
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)

← 1 2 3 4 5 →